A detailed history of Tang Capital Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Tang Capital Management LLC holds 270,000 shares of BNTX stock, worth $27.6 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
270,000
Holding current value
$27.6 Million
% of portfolio
2.73%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $21.2 Million - $33.7 Million
270,000 New
270,000 $32.1 Million
Q4 2022

Feb 14, 2023

SELL
$118.43 - $186.05 $1.18 Million - $1.86 Million
-10,000 Reduced 25.0%
30,000 $4.51 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $5.05 Million - $9.27 Million
40,000 New
40,000 $6.82 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.